CLINICAL_TRIALS
trial_result
· 2021-04-19
Clinical Trial Update: Midodrine and Fludrocortisone for Vasovagal Syncope [Phase 3]
Summary
Phase 3 trial update for midodrine and fludrocortisone in vasovagal syncope.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tehran Heart Center | Conditions: Syncope, Vasovagal | Phase 3 | Status: UNKNOWN